Summary
Patient preferences when using medicine is already part of the approval process for new medicines in FDA and EMA and similar procedures are pending within NICE (UK).
At this hot topic seminar, you gain an understanding of how patient perspectives and patient preferences can be used to demonstrate the value of pharmaceutical products. Specifically, you will hear representatives from NICE and the Danish Medicines Council discuss how NICE and The Danish Medicines Council respectively regard such data.
You will learn from real-life case examples from:
- Centre for joint decision-making, Lillebælt Hospital
- Lundbeck
- NICE
Please note: two lectures are conducted in English, and three lectures will be presented via video link.
Keywords
- Patient preferences
- Patient Advocacy
- Medical Affairs
- HTA processes
- NICE
Save information for later

Course leader & lecturers
- Elisabeth Gammelgaard LudvigCourse leaderOwner
Sundhedsagenda - Jørgen Schøler KristensenLecturerKst Koncerndirektør
Medicinrådet - Karina Dahl SteffensenLecturerProfessor, Cheflæge, Center for Fælles Beslutningstagning
Sygehus Lillebælt - Agathe Le LayLecturerSenior Director and Global Head of Value Evidence
Lundbeck A/S
Is this course for you?
Join this course if you work in a consultant or pharmaceutical company with medical affairs, market access, public affairs, sales & marketing, and patient advocacy.
What you will learn
- Understand what patient preferences are, and how they can be generated qualitatively and quantitatively.
- Learn how NICE views patient preference data, and how (& if?) The Danish Medicines Council (Medicinrådet) expects to include patient preferences in its future considerations.
- Learn how a pharma HQ works with patient preference data in HTA processes.
- Understand how Danish HCPs work with patient involvement and patient preferences in joint decision making when choosing treatment type, and how pharma companies can support this work.
What your company will get
- An employee who understands patient preferences and how these can be developed.
- An employee who understands how patient preferences can be utilised in cross-functional work within a pharma company in drug development, during market access and during launch.
Course calendar
Day 1
- How do physicians work with patient preferences and joint decision making in the daily clinic?
- How to use patients’ perspectives and preferences to demonstrate the value of therapeutic interventions
- Use of patient preference studies in HTA decision making: a perspective from NICE
- The Danish Medicines Council’s (Medicinrådets) view on patient preference data and their role in the future work of the council
- Lunch and networking
Registration
Registration deadline26 Oct 2023
Lersø Parkallé 101
2100 København Ø
Course information
Literature
Mandatory readings:
Prerequisites
Industry knowledge is an advantage.
Examination
There is no examination for this course.
Course leader
Sundhedsagenda
Lecturers
Medicinrådet
Sygehus Lillebælt
Lundbeck A/S
You may also be interested in these courses
Want to know more or need help?
Contact Client Manager Christina Spangsberg at +45 39 15 09 22